The global Brain Pacemaker Market represents a rapidly expanding segment of the medical device industry, valued at USD 3.66 ...

Minnesota CEOs crowded around the golden opening bell of the New York Stock Exchange on Thursday morning, not on Wall Street ...

RATES of permanent pacemaker implantation (PPI) exceed 20% in patients with aortic regurgitation (AR). A new retrospective ...

However, in the postreform healthcare world where there are higher hurdles for securing reimbursement for next-generation technology, Medtronic has had to move in the direction of introducing ...

Medtronic's growth strategies, dividend stability, and innovation focus amidst debt concerns and market risks. Click here to ...

The uptick in the historic period can be linked to an increased preference for home-based cardiac monitoring, an enhancement in the number of cardiac surgeries and implantations, a burgeoning demand ...

The findings highlight the importance of having an EP versed in lead management on the heart valve team, one expert says.

Here at the New York Valves meeting, hosted by the Cardiovascular Research Foundation, panelists mulled over the options: either transvenous lead extraction or entrapment ("jailing") of the lead by ...

Extract or Jail? A Case Report on Transcatheter Tricuspid Valve Replacement in the Presence of Pacemaker Lead Related Tricuspid Regurgitation and Complex Anatomy ...

Medline has expanded a correction involving procedure kits containing its Medtronic aortic root cannulas, due to risk of serious injury or death. The expanded recall comes after Medline confirmed more ...

Methods The two regional studies utilized a lumenless, bipolar, permanent pacing lead (SelectSecure™ lead model 3830, Medtronic, Inc.) (Fig. 1). This 4.1-Fr-diameter, active fixation, steroid ...

The study results support the electrical efficacy and safety of a catheter-delivered, lumenless lead in traditional or alternate right atrium or right ventricle sites through 18 months post-implant.